Skip to content

Adjuvant diagnosis of urothelial carcinoma based on urine DNA methylation qPCR

Adjuvant diagnosis of urothelial carcinoma based on urine DNA methylation qPCR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093931
Enrollment
Unknown
Registered
2024-12-13
Start date
2024-06-19
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urothelial carcinoma

Interventions

case:urothelial carcinoma
control:non urothelial carcinoma

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Sign the informed consent document; 2.Aged >= 18 years old; 3.Subject with suspected urothelial carcinoma; 4.Subjects with urothelial carcinoma undergoing secondary resection; 5.Subjects with urothelial carcinoma following routine microscopic examination; 6.Subjects with other malignancies of the urinary system that have been pathologically diagnosed as non-urothelial carcinoma;

Exclusion criteria

Exclusion criteria: 1.Subjects with a prior history of malignancy; 2.Subjects with other systemic tumors combined with urothelial carcinoma; 3.Subjects who have received chemotherapy in the last two weeks;

Design outcomes

Primary

MeasureTime frame
Specificity;Sensitivity;

Countries

China

Contacts

Public ContactYa-Wen Xu

Zhujiang Hospital of Southern Medical University

mouse72@foxmail.com+86 13316085011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026